Sunday, June 14, 2026

Latest

Aphria Reports Independent Proxy Firms Approve Of Tilray Merger

Aphria Inc (TSX: APHA) (NASDAQ: APHA) is evidently looking to drum up shareholder support for its proposed transaction with Tilray Inc (NASDAQ: TLRY). The firm this morning released that two separate proxy advisory firms have provided favourable voting recommendations to institutional investors for the transaction.

The two firms, Institutional Shareholder Services, and Glass Lewis and CO, have reportedly recommended that shareholders voting in favour of the transaction. In reaching its conclusion, ISS reportedly highlighted US$78 million in pre-tax cost synergies within two years of the transaction closing as well as the pro-forma revenue figures as being a large part of its positive recommendation. Also highlighted was the pro-forma European operations that include both cultivation and distribution across the EU.

Glass Lewis meanwhile was much less specific in its conclusion, instead referencing that the transaction implies “a standard market premium,” for both entities within the transaction.

Shareholders are set to vote on the transaction on April 14 at a special meeting.

Aphria Inc last traded at $22.75 on the TSX.


Information for this briefing was found via Sedar and Aphria Inc. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

The Canadian Dream Is Leaving Canada | Spencer Gatten

Allied Gold: The Zijin Deal Is On The Rocks

Why Silver’s Drop May Not Mean the Bull Market Is Over | Peter Krauth

Recommended

Silver47 Starts 10,000 Metre Campaign at Flagship Alaska Silver Project

Blue Jay Gold Launches 16,000 Metre Drill Program At Steller

Related News

Aphria Finally Completes First Medical Cannabis Shipment To Germany

The exports to Germany have finally begun for Aphria (TSX: APHA) (NASDAQ: APHA). After touting...

Wednesday, October 7, 2020, 08:51:47 AM

Tilray Imports Medical Cannabis to USA to Assist Research on Breast Cancer Related Disorder

Tilray Inc (NASDAQ: TLRY) announced this morning that it has successfully imported medical cannabis from...

Thursday, October 24, 2019, 09:15:29 AM

Aphria Diamond Receives Cultivation License

It’s finally happened. Aphra Inc’s (TSX: APHA) (NYSE: APHA) Aphria Diamond facility has finally received...

Friday, November 1, 2019, 05:23:47 PM

Hexo To Be Acquired By Tilray For US$56.0 Million

It appears that Sebastian St-Louis’s “billion dollar start-up” has finally been sold. Hexo Corp (TSX:...

Monday, April 10, 2023, 05:26:52 PM

Tilray Sees Gotham Green Look To Sell Recently Acquired Shares

It appears that Gotham Green Partners has approximately zero interest in being a shareholder of...

Monday, September 20, 2021, 08:32:00 AM